home > drugs a-z list > miraluma (technetium tc99m sestamibi) drug center

Miraluma

font size

Miraluma Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Miraluma Prescribing Information: Indications & Dosage

Myocardial Imaging: CARDIOLITE®, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. CARDIOLITE® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress a...

Read the complete drug monograph for Miraluma »

What is Miraluma Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

Related Resources for Miraluma

© Miraluma Patient Information is supplied by Cerner Multum, Inc. and Miraluma Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Additional Miraluma Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Privacy Policy

Heart Health

Get the latest treatment options.


From WebMD

Healthy Heart Resources
Featured Centers
Health Solutions From Our Sponsors